Description
| Product Name | Format | CAT.No | Size |
| Urea GLDH Kinetic & Endpoint | Lyo | BXC0121A | R1: 1 x 105ml R2: 5 x 20ml R4: 1 x 5ml |
| Urea GLDH Kinetic & Endpoint | Lyo | BXC0121B | R1: 2 x 105ml R2: 10 x 20ml R4: 1 x 5ml |
| Urea Modified Berthelot | LS | BXC0122A | R1: 2 x 125ml R2: 1 x 50ml R3: 2 x 6.5ml R4: 1 x 5ml |
| Urea Modified Berthelot | LS | BXC0122B | R1: 4 x 125ml R2: 2 x 50ml R3: 4 x 6.5ml R4: 1 x 5ml |
| Urea GLDH Kinetic & Endpoint | LS | BXC0123A | R1: 1 x 100ml R2: 1 x 20ml R4: 1 x 5ml |
| Urea GLDH Kinetic & Endpoint | LS | BXC0123B | R1: 3 x 100ml R2: 1 x 60ml R4: 1 x 5ml |
| Urea GLDH Kinetic & Endpoint | LS | BXC0123C | R1: 5 x 100ml R2: 1 x 100ml R4: 1 x 5ml |
| Urea GLDH Kinetic & Endpoint DGKC 4+1 | LS | BXC0124A | R1: 1 x 100ml R2: 1 x 25ml R4:1 x 5ml |
| Urea GLDH | Mono | BXC0126A | R1: 1 x 100ml R4: 1 x 5ml |
Product Description
The Biorex Diagnostics Urea GLDH Assay is a ready-to-use quantitative test for the measurement of urea in human serum, plasma, and urine, providing essential insights into renal function, protein metabolism, and overall nitrogen balance. This assay offers clinicians and laboratory professionals a reliable tool for the assessment of kidney health, metabolic efficiency, and patient nutritional status. Monitoring these parameters is critical for detecting early signs of renal impairment, evaluating protein catabolism, and managing patients with metabolic or systemic disorders.
Key Features
- Quantitative determination in serum, plasma, and urine samples for comprehensive metabolic evaluation
- Supports clinical assessment of kidney function, protein breakdown, and metabolic balance
- Enables differentiation of prerenal, renal, and postrenal causes of abnormal nitrogen levels
- Ready-to-use reagents streamline laboratory workflow, reduce pre-analytical errors, and enhance throughput
- Compatible with both manual procedures and automated clinical chemistry analysers, ensuring versatility across laboratory settings
Benefits
This assay delivers precise, reproducible, and clinically relevant data that empower healthcare professionals to make informed decisions. Accurate measurement is vital for monitoring patients with renal disease, metabolic disorders, or conditions affecting protein turnover. The assay’s design minimizes variability and enhances analytical reliability, supporting laboratories in achieving consistent performance across multiple platforms and high-volume testing environments.
Its ready-to-use format simplifies preparation, reduces potential human error, and saves valuable technician time, making it ideal for hospital laboratories, nephrology departments, critical care units, and research facilities. By providing timely and dependable results, the test aids in the early identification of renal dysfunction, the evaluation of metabolic status, and the guidance of therapeutic interventions, improving patient outcomes and supporting evidence-based clinical practice.
Beyond routine diagnostics, this assay serves as a powerful tool in research applications, including studies on nitrogen metabolism, renal physiology, and protein catabolism. The broad applicability across different sample types ensures that laboratories can obtain a comprehensive picture of a patient’s metabolic and renal health.
In summary, the Biorex Diagnostics assay is an indispensable component of modern clinical laboratories. Its combination of accuracy, reproducibility, versatility, and ease of use makes it essential for both routine patient monitoring and advanced research. By supporting timely clinical evaluation and facilitating effective management of renal and metabolic disorders, this assay enhances diagnostic capabilities, operational efficiency, and patient care outcomes.
Contact Us for more information